Alphatec Spine

As a global medical technology company, focused on addressing disorders of the spine, we strive to fulfill our purpose of ‘improving lives by delivering advancements in spinal fusion technologies’. We are dedicated to the design, development, launch and promotion of spinal fusion products, with one of our core objectives being, to help patients ‘live better’. We seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. Our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of improving patient outcomes. Represented in more than 60 countries, Alphatec Spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care.
Company Growth (employees)
Type
Public
HQ
Carlsbad, US
Founded
1990
Size (employees)
430 (est)
Alphatec Spine was founded in 1990 and is headquartered in Carlsbad, US

Alphatec Spine Office Locations

Alphatec Spine has an office in Carlsbad
Carlsbad, US (HQ)
5818 El Camino Real

Alphatec Spine Data and Metrics

Alphatec Spine Financial Metrics

Alphatec Spine's revenue was reported to be $28 m in Q1, 2017
USD

Revenue (Q1, 2017)

28 m

Gross profit (Q1, 2017)

16.8 m

Gross profit margin (Q1, 2017), %

60%

Net income (Q1, 2017)

(5.5 m)

EBIT (Q1, 2017)

(3.4 m)

Market capitalization (22-Aug-2017)

21.2 m

Cash (31-Mar-2017)

25.5 m
Alphatec Spine's current market capitalization is $21.2 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

204.7 m207 m185.3 m120.2 m

Revenue growth, %

1%(10%)(35%)

Cost of goods sold

78.7 m61.8 m63.7 m44.1 m

Gross profit

126.1 m145.1 m121.5 m76.1 m

Gross profit Margin, %

62%70%66%63%

Sales and marketing expense

51 m

R&D expense

9.2 m

General and administrative expense

26.3 m

Operating expense total

86.5 m

EBIT

(73.4 m)1.8 m(172.4 m)(15.4 m)

EBIT margin, %

(36%)1%(93%)(13%)

Interest expense

4 m13.6 m12.6 m5.4 m

Interest income

6 k10 k53 k3 k

Pre tax profit

(178 m)

Income tax expense

3.2 m1.1 m681 k(4.6 m)

Net Income

(82.2 m)(12.9 m)(178.7 m)(29.9 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

53.2 m51 m48.6 m46.6 m43 m44.8 m43.8 m26.7 m28 m

Cost of goods sold

16.6 m14.3 m15.3 m18.7 m14.2 m13.5 m15.5 m10.8 m11.2 m

Gross profit

36.6 m36.7 m33.3 m27.9 m28.8 m31.2 m28.3 m15.9 m16.8 m

Gross profit Margin, %

69%72%68%60%67%70%65%59%60%

Sales and marketing expense

19.8 m18.6 m18.2 m16.6 m17.1 m19.1 m18.1 m11.8 m11.1 m

R&D expense

4.5 m4.4 m3.9 m3.9 m1.9 m3.7 m2.1 m1.1 m1.4 m

General and administrative expense

9.2 m10.2 m9.1 m9.2 m8.1 m10.6 m8.3 m4.1 m6.2 m

Operating expense total

33.6 m33.3 m31.2 m29.8 m27.1 m33.4 m28.5 m17 m18.8 m

EBIT

1.8 m1.7 m1.1 m(2.8 m)(164.9 m)(3.7 m)(1.2 m)(4.5 m)(3.4 m)

EBIT margin, %

3%3%2%(6%)(384%)(8%)(3%)(17%)(12%)

Interest expense

3.7 m3.9 m3.4 m3 m3.1 m3.4 m3.7 m1.1 m2 m

Interest income

3 k2 k7 k12 k18 k20 k16 k

Income tax expense

307 k(28 k)902 k253 k(1.7 m)586 k600 k(5 m)49 k

Net Income

(2.9 m)(3 m)(4.6 m)(3.9 m)(160.3 m)(6.6 m)(5.2 m)(13.7 m)(5.5 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

21.3 m19.7 m11.2 m19.6 m

Accounts Receivable

41.4 m40.4 m38.3 m18.5 m

Inventories

7.7 m5.5 m5.1 m30.1 m

Current Assets

113.7 m113.1 m101.9 m72.8 m

PP&E

28 m26 m21.9 m15.1 m

Goodwill

183 m171.3 m

Total Assets

365.6 m344.9 m146.7 m94.2 m

Accounts Payable

10.8 m10.1 m14.2 m8.7 m

Total Debt

3.1 m

Current Liabilities

79.7 m63.6 m125.4 m40.1 m

Additional Paid-in Capital

403.6 m413.9 m416.9 m419.8 m

Retained Earnings

(235.7 m)(248.6 m)(427.2 m)(457.2 m)

Debt to Assets Ratio

0 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

19 m20.2 m11.4 m8.9 m10.5 m7.8 m9.3 m25.6 m25.5 m

Accounts Receivable

44.7 m40.1 m38.9 m38.9 m36.3 m39.4 m36.5 m16.5 m14.2 m

Inventories

42.4 m42 m41.8 m41.2 m42.3 m48 m44.1 m27.7 m30.1 m

Current Assets

117.4 m112.7 m102.5 m100.1 m100.3 m100.3 m93.7 m75.6 m72.4 m

PP&E

27.4 m26.5 m25.9 m23.8 m23.7 m22.7 m21.6 m13.7 m15.4 m

Goodwill

182.3 m175.1 m161.7 m163.8 m

Total Assets

364.7 m348.6 m320.1 m314.2 m148.4 m145.4 m136.5 m96 m93.6 m

Accounts Payable

14 m11.3 m8.9 m10.4 m10.8 m19.3 m17.4 m6.8 m4.2 m

Current Liabilities

69.8 m66.2 m56.7 m53.3 m98.6 m129.6 m125.2 m42.4 m33.3 m

Additional Paid-in Capital

411 m412.6 m415.2 m416.7 m416.6 m417 m417.4 m418.9 m437.5 m

Retained Earnings

(245.3 m)(248.3 m)(253.1 m)(257.1 m)(417.3 m)(433.9 m)(439.1 m)(452.8 m)(462.7 m)

Total Equity

133.6 m

Financial Leverage

2.4 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(82.2 m)(12.9 m)(178.7 m)(29.9 m)

Depreciation and Amortization

26.3 m18.4 m19 m934 k

Accounts Receivable

(1.9 m)(1 m)1.2 m8 m

Inventories

(4.4 m)(4.3 m)(5.5 m)(5.7 m)

Accounts Payable

(3.9 m)(1 m)3.2 m(4.9 m)

Cash From Operating Activities

7.8 m(20.3 m)10.1 m(10 m)

Purchases of PP&E

(14.4 m)(11.3 m)(12.2 m)(8.9 m)

Cash From Investing Activities

(19.1 m)(11 m)(12.2 m)62 m

Short-term Borrowings

(2.7 m)(5.8 m)(8.2 m)(54.4 m)

Cash From Financing Activities

10.7 m30.7 m(6.5 m)(43.4 m)

Interest Paid

4 m5.9 m7.6 m7.4 m

Income Taxes Paid

1.8 m565 k621 k920 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(2.9 m)(3 m)(4.6 m)(3.9 m)(160.3 m)(6.6 m)(5.2 m)(13.7 m)(5.5 m)

Depreciation and Amortization

172 k

Accounts Receivable

44.7 m40.1 m38.9 m38.9 m36.3 m39.4 m36.5 m16.5 m14.2 m

Accounts Payable

14 m11.3 m8.9 m10.4 m10.8 m19.3 m17.4 m6.8 m4.2 m
USDY, 2017

Revenue/Employee

65.1 k

Alphatec Spine Market Value History

Traffic Overview of Alphatec Spine

Alphatec Spine Online and Social Media Presence

Alphatec Spine Company Life and Culture

You may also be interested in